CAPR Stock

Roth Capital analyst Boobalan Pachaiyappan lowered his target on Capricor Therapeutics (Capricor The... Read More

Roth Capital Markets analyst Boobalan Pachaiyappan said in a Nov. 25 report that Capricor Therapeuti... Read More